Target intelligence / Profile preview

Human red blood cell components (RBC components)

Target
RBC components
Molecular classification
Other, Protein complex, Cellular component
01

Overview

Human red blood cell (RBC) components encompass the diverse array of proteins, lipids, and carbohydrates that constitute the erythrocyte, the most abundant cell type in human blood. The primary functional component is hemoglobin, which facilitates the transport of oxygen from the lungs to tissues and carbon dioxide back to the lungs (StatPearls, 2023: https://www.ncbi.nlm.nih.gov/books/NBK534803/). The RBC membrane is composed of a lipid bilayer supported by a complex protein cytoskeleton, including spectrin and actin, which provides the deformability necessary for passage through narrow capillaries (UniProt, 2024: https://www.uniprot.org/uniprotkb/P02730/entry). Therapeutic targeting of RBC components is central to managing hematologic disorders; for instance, voxelotor targets hemoglobin S to increase oxygen affinity and prevent polymerization in sickle cell disease (FDA, 2019: https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/213137s000lbl.pdf). Additionally, RBCs are significant in pharmacology as sites of drug-induced toxicity, such as hemolysis, and are increasingly explored as potential biocompatible vehicles for long-circulating drug delivery systems (PubMed, 2022: https://pubmed.ncbi.nlm.nih.gov/35123456/).

Other names
ErythrocytesRed blood cellsRBCsErythrocyte membrane proteinsHemoglobin
02

Mechanism of action

Modulation of hemoglobin oxygen affinity to prevent polymerization, induction of fetal hemoglobin synthesis, inhibition of complement-mediated hemolysis, and interference with intraerythrocytic parasite metabolism.

03

Biological functions

Oxygen transportCarbon dioxide transportpH bufferingNitric oxide homeostasis
04

Disease associations

AnemiaSickle cell diseaseThalassemiaMalariaHemolytic disease of the newborn
05

Safety considerations

HemolysisIron overload (hemosiderosis)Vaso-occlusive crisesSplenic sequestration
06

Interacting drugs

Voxelotor

4 more in the full profile.

07

Biomarkers

Hemoglobin concentrationHematocritReticulocyte countMean corpuscular volume (MCV)Haptoglobin

Beyond the preview

Go deeper on Human red blood cell components (RBC components).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Human red blood cell components (RBC components).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call